A combined enzymatic and proteomic approach has also been exploited to identify the Metarhizium anisopliae response to the chitin-containing exoskeleton of the cowpea weevil plant pathogen (Callosobruchus maculatus) (Murad et al., 2006). Enhanced protein secretion (fivefold) from M. anisopliae was observed in the presence of C. maculatus exoskeleton. Specifically, elevated chitinolytic and proteolytic activities were observed and 2D-PAGE revealed the expression of seven additional proteins during exposure; however, definitive identification was not initially confirmed by protein mass spectrometry. Subsequently, Murad et al. (2008)

identified N-acetyl-d-glucosamine kinase and d-glucosamine N-acetyltransferase in the M. anisopliae secretome, following 3-MA research buy exoskeleton co-incubation, by 2D-PAGE and MALDI-ToF/ToF MS. Murad and colleagues proposed that chitosan adsorption by M. anisopliae was facilitated, in part, by these enzymes because chitosan is more soluble, and therefore,

more readily absorbed as a nutrient by M. anisopliae, than chitin. Combining mass spectrometry-based protein identification with the specificity of immunoblotting represents an emerging strategy for the identification of immunoreactive fungal antigens, some of which may be potent allergens (Doyle, 2011). This research strategy has found particular use in exploring U0126 cell line the immunoproteome, or ‘immunome’, of C. albicans, Cryptococcus spp. and A. fumigatus. Pitarch et al. (2004) detected 85 C. albicans proteins that were immunoreactive with systemic candidiasis patient sera, using a combination of MALDI-ToF MS and nanoelectrospray ionization-ion trap (ESI-IT) MS. Furthermore, they also observed, for the first time, that 35 of the immunoreactive proteins were targets of the human antibody response to systemic candidiasis, and that the production

of antiphosphoglycerate kinase and alcohol dehydrogenase antibodies during systemic candidiasis might be linked to a differentiation of the human immune response to C. albicans. Increased selleck antibody antienolase antibody levels appeared to be associated with recovery from systemic candidiasis in this patient cohort, providing the possibility of predicting patient outcome using an immunoproteomic strategy. Pitarch et al. (2006) subsequently demonstrated that serum antienolase (cell wall associated) antibodies were a prognostic indicator for systemic candidiasis and that this protein, along with Bgl2p, may be candidates for Candida vaccine development. Recent immunoprotoemic work furthers these findings with respect to immunotherapy against invasive candidiasis (Pitarch et al., 2011). Cryptococcosis is a potentially fatal fungal disease of humans and other animals (Datta et al., 2009).